Short Interest in PURE Bioscience, Inc. (OTCMKTS:PURE) Rises By 50.0%

PURE Bioscience, Inc. (OTCMKTS:PURE) was the target of a significant growth in short interest in March. As of March 15th, there was short interest totalling 900 shares, a growth of 50.0% from the February 28th total of 600 shares. Based on an average daily trading volume, of 106,200 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the company’s stock are sold short.

PURE Bioscience Trading Up 4.2 %

PURE stock traded up $0.00 during mid-day trading on Friday, hitting $0.09. 95,672 shares of the company were exchanged, compared to its average volume of 65,329. The firm has a fifty day simple moving average of $0.07 and a 200 day simple moving average of $0.08. The company has a market capitalization of $10.30 million, a PE ratio of -2.30 and a beta of 0.35. PURE Bioscience has a twelve month low of $0.05 and a twelve month high of $0.16.

PURE Bioscience (OTCMKTS:PURE) last announced its quarterly earnings data on Monday, March 17th. The company reported ($0.01) earnings per share for the quarter. The company had revenue of $0.39 million during the quarter.

PURE Bioscience Company Profile

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.